Academia
Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.
We write about science every day, why isn’t it getting through to the public consciousness?
Biologist Dr. Pablo Juan Ross is no stranger to cutting-edge tools such as CRISPR and stem cells.
The way the university handled it violated state law, according to state officials.
PRESS RELEASES